Authors:
Ohdo, S
Koyanagi, S
Suyama, H
Higuchi, S
Aramaki, H
Citation: S. Ohdo et al., Changing the dosing schedule minimizes the disruptive effects of interferon on clock function, NAT MED, 7(3), 2001, pp. 356-360
Authors:
Hayashi, N
Aso, H
Higashida, M
Kinoshita, H
Ohdo, S
Yukawa, E
Higuchi, S
Citation: N. Hayashi et al., Estimation of rhG-CSF absorption kinetics after subcutaneous administration using a modified Wagner-Nelson method with a nonlinear elimination model, EUR J PH SC, 13(2), 2001, pp. 151-158
Authors:
Yukawa, E
Suematu, F
Yukawa, M
Minemoto, M
Ohdo, S
Higuchi, S
Goto, Y
Aoyama, T
Citation: E. Yukawa et al., Population pharmacokinetics of digoxin in Japanese patients - A 2-compartment pharmacokinetic model, CLIN PHARMA, 40(10), 2001, pp. 773-781
Authors:
Yukawa, E
Nonaka, T
Yukawa, M
Ohdo, S
Higuchi, S
Kuroda, T
Goto, Y
Citation: E. Yukawa et al., Pharmacoepidemiologic investigation of a clonazepam-carbamazepine interaction by mixed effect modeling using routine clinical pharmacokinetic data inJapanese patients, J CL PSYCH, 21(6), 2001, pp. 588-593
Authors:
Yukawa, E
Satou, M
Nonaka, T
Yukawa, M
Ohdo, S
Higuchi, S
Kuroda, T
Goto, Y
Citation: E. Yukawa et al., Influence of age and comedication on steady-state clonazepam serum level-dose ratios in Japanese epileptic patients, J CLIN PH T, 26(5), 2001, pp. 375-379
Authors:
Wang, DS
Ohdo, S
Koyanagi, S
Takane, H
Aramaki, H
Yukawa, E
Higuchi, S
Citation: Ds. Wang et al., Effect of dosing schedule on pharmacokinetics of alpha interferon and anti-alpha interferon neutralizing antibody in mice, ANTIM AG CH, 45(1), 2001, pp. 176-180
Authors:
Suematsu, F
Yukawa, E
Yukawa, M
Minemoto, M
Ohdo, S
Higuchi, S
Goto, Y
Citation: F. Suematsu et al., Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis, EUR J CL PH, 57(1), 2001, pp. 19-24
Authors:
Takane, H
Ohdo, S
Yamada, T
Koyanagi, S
Yukawa, E
Higuchi, S
Citation: H. Takane et al., Relationship between diurnal rhythm of cell cycle and interferon receptor expression in implanted-tumor cells, LIFE SCI, 68(12), 2001, pp. 1449-1455
Citation: J. Viyoch et al., Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice, J PHARM EXP, 298(3), 2001, pp. 964-969
Authors:
Yukawa, E
Hokazono, T
Funakoshi, A
Yukawa, M
Ohdo, S
Higuchi, S
Ichimaru, R
Maki, T
Matsunaga, K
Anai, M
Goto, Y
Citation: E. Yukawa et al., Epidemiologic investigation of the relative clearance of haloperidol by mixed-effect modeling using routine clinical pharmacokinetic data in Japanesepatients, J CL PSYCH, 20(6), 2000, pp. 685-690
Authors:
Ohdo, S
Wang, DS
Koyanagi, S
Takane, H
Inoue, K
Aramaki, H
Yukawa, E
Higuchi, S
Citation: S. Ohdo et al., Basis for dosing time-dependent changes in the antiviral activity of interferon-alpha in mice, J PHARM EXP, 294(2), 2000, pp. 488-493
Authors:
Takane, H
Ohdo, S
Yamada, T
Yukawa, E
Higuchi, S
Citation: H. Takane et al., Chronopharmacology of antitumor effect induced by interferon-beta in tumor-bearing mice, J PHARM EXP, 294(2), 2000, pp. 746-752
Authors:
Terashi, K
Oka, M
Ohdo, S
Furukubo, T
Ikeda, C
Fukuda, M
Soda, H
Higuchi, S
Kohno, S
Citation: K. Terashi et al., Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients, ANTIM AG CH, 43(1), 1999, pp. 21-24